Similar articles

• Nonequilibrium alpha adrenergic blockade and neuroleptic activity of N-ethoxycarbonyl-1,dihydroquinoline (BC-347).

  Martel RR. Martel RR. J Pharmacol Exp Ther. 1969 Mar;166(1):44-51. J Pharmacol Exp Ther. 1969. PMID: 4304784 No abstract available.
• The comparative pharmacology of WG253 (rimiterol hydrobromide), a new bronchodilator.

  Carney I, Daly MJ, Lightowler JE, Pickering RW. Carney I, et al. Arch Int Pharmacodyn Ther. 1971 Dec;194(2):334-45. Arch Int Pharmacodyn Ther. 1971. PMID: 4399467 No abstract available.
• Studies on tetrahydroisoquinolines (THI). VI. Effects of trimetoquinol on tracheal and some other smooth muscles.

  Kiyomoto A, Iwasawa Y, Harigaya S. Kiyomoto A, et al. Arzneimittelforschung. 1970 Jan;20(1):46-52. Arzneimittelforschung. 1970. PMID: 4392500 No abstract available.
• Structure-activity relationships in the adrenergic-blocking agents.

  Ghouri MS, Haley TJ. Ghouri MS, et al. J Pharm Sci. 1969 May;58(5):511-38. doi: 10.1002/jps.2600580502. J Pharm Sci. 1969. PMID: 4389589 Review. No abstract available.
• Drugs affecting smooth muscle.

  Miller JW, Lewis JE. Miller JW, et al. Annu Rev Pharmacol. 1969;9:147-72. doi: 10.1146/annurev.pa.09.040169.001051. Annu Rev Pharmacol. 1969. PMID: 4892428 Review. No abstract available.